Top 10 Companies in the Pyrantel Pamoate Industry (2025): Market Leaders in Anthelmintic Solutions

In Business Insights
June 03, 2025

The Global Pyrantel Pamoate Market was valued at USD 129 Million in 2023 and is projected to reach USD 164.12 Million by 2032 growing at a Compound Annual Growth Rate (CAGR) of 3.5% during the forecast period (2024-2032). This growth is driven by increasing prevalence of parasitic infections, rising veterinary healthcare needs, and expanding pharmaceutical production capabilities in emerging markets.

As global health awareness improves and pet ownership rises worldwide, pharmaceutical companies are scaling production of this critical anthelmintic medication. In this analysis, we examine the Top 10 Companies in the Pyrantel Pamoate Industry – featuring API manufacturers, formulation specialists, and veterinary health leaders shaping treatment protocols.


🔟 1. Uquifa

Headquarters: Barcelona, Spain
Key Offering: Pyrantel Pamoate API and formulations (98%+ purity)

Uquifa is a globally recognized active pharmaceutical ingredient (API) manufacturer with extensive expertise in anthelmintic compounds. The company supplies pyrantel pamoate to major pharmaceutical companies worldwide, maintaining strict quality compliance across multiple regulatory jurisdictions.

Key Strengths:

  • GMP-certified manufacturing facilities in Europe and Latin America
  • Strategic partnerships with global generic drug manufacturers
  • Vertical integration in chemical synthesis of antiparasitic compounds

Download FREE Sample Report: Pyrantel Pamoate Market – View in Detailed Research Report


9️⃣ 2. Megafine Pharma

Headquarters: Mumbai, India
Key Offering: High-purity Pyrantel Pamoate (veterinary and human grade)

Megafine has emerged as a leading supplier of pyrantel pamoate from India, benefiting from the country’s strong API manufacturing infrastructure. The company serves both domestic pharmaceutical firms and international markets with competitively priced, quality-approved products.

Key Strengths:

  • FDA-approved manufacturing facility
  • Specialization in cost-effective bulk drug production
  • Expanding presence in African and Southeast Asian markets

8️⃣ 3. Ipca Laboratories

Headquarters: Mumbai, India
Key Offering: Branded and generic pyrantel formulations

Ipca Laboratories is one of India’s most respected pharmaceutical companies with significant market share in both human anthelmintic treatments and veterinary deworming products. The company markets pyrantel pamoate under multiple brand names.

Key Strengths:

  • Strong distribution network across 120+ countries
  • Comprehensive portfolio of antiparasitic medications
  • Ongoing R&D in combination anthelmintic therapy

7️⃣ 4. Cosma

Headquarters: Milan, Italy
Key Offering: Pharmaceutical-grade pyrantel pamoate

Cosma specializes in niche pharmaceutical ingredients with a focus on antiparasitic compounds. The Italian firm supplies pyrantel pamoate to European and North American drug manufacturers while maintaining strict regulatory compliance.

Key Strengths:

  • EDQM and FDA-compliant manufacturing
  • Custom synthesis capabilities for specialized formulations
  • Strong technical support for formulation development

Download FREE Sample Report: Pyrantel Pamoate Market – View in Detailed Research Report


6️⃣ 5. Minsheng Medicine

Headquarters: Hangzhou, China
Key Offering: Pyrantel Pamoate API and veterinary formulations

Minsheng Medicine is a major Chinese producer of anthelmintic APIs with growing international exports. The company has significantly expanded its pyrantel pamoate production capacity to meet increasing global demand.

Key Strengths:

  • Cost-effective high-volume manufacturing
  • GMP certification for multiple international markets
  • Strategic focus on animal health applications

5️⃣ 6. Hubei Zhongjia Chemical

Headquarters: Wuhan, China
Key Offering: Pyrantel Pamoate technical material

This Chinese chemical manufacturer has become a key supplier of pyrantel pamoate intermediate products, providing cost-effective solutions for API manufacturers globally through continuous process optimization.

Key Strengths:

  • Vertically integrated production facility
  • Competitive pricing structure
  • Flexible customization options

4️⃣ 7. K.A. Malle Pharma

Headquarters: Mumbai, India
Key Offering: Veterinary pyrantel formulations

Specializing in animal health products, this Indian firm has developed specialized pyrantel pamoate formulations for livestock and companion animals, widely used in deworming protocols across Asia and Africa.

Key Strengths:

  • Specialized veterinary dosage forms
  • Palatable formulations for companion animals
  • Strong presence in developing markets

3️⃣ 8. Manus Aktteva Biopharma

Headquarters: Ahmedabad, India
Key Offering: Pyrantel Pamoate API and intermediates

Manus Aktteva has established itself as a reliable supplier of pyrantel pamoate with consistent quality standards, serving both domestic formulation manufacturers and international clients.

Key Strengths:

  • Multiple manufacturing site approvals
  • Diversified API portfolio
  • Agile response to market demand fluctuations

2️⃣ 9. GlaxoSmithKline

Headquarters: London, UK
Key Offering: Branded pyrantel combination products

GSK markets some of the world’s most recognized pyrantel-based anthelmintic brands, with combination therapies demonstrating high efficacy in treating mixed parasitic infections.

Key Strengths:

  • Global brand recognition
  • Extensive clinical validation
  • Strong healthcare professional acceptance

1️⃣ 10. Zoetis

Headquarters: Parsippany, New Jersey, USA
Key Offering: Veterinary pyrantel formulations

Zoetis incorporates pyrantel pamoate in several of its award-winning antiparasitic products, with R&D focused on optimized formulations for different animal species and age groups.

Key Strengths:

  • Extensive veterinary distribution network
  • Species-specific formulations
  • Comprehensive parasite control programs

Read Full Report: Pyrantel Pamoate Market – View in Detailed Research Report


🌍 Outlook: The Future of Pyrantel Pamoate Market

The anthelmintic drug market continues to evolve with new formulation technologies and combination therapies. While generic competition remains strong, opportunities exist in veterinary applications and emerging markets with high parasite burdens.

📈 Key Trends Shaping the Market:

  • Growing demand for triple-combination antiparasitic drugs
  • Increasing pet ownership driving veterinary market growth
  • Expansion of pharmaceutical manufacturing in Asia
  • Rising awareness about soil-transmitted helminthiases in developing nations

Read Full Report: Pyrantel Pamoate Market – View in Detailed Research Report